PremiumCompany AnnouncementsArecor Therapeutics Appoints New Auditor PKF Littlejohn LLP Arecor Therapeutics Establishes Expert Advisory Board for Oral Peptide Delivery Arecor Therapeutics Grants New Share Options to Drive Growth PremiumCompany AnnouncementsArecor Chair Increases Stake with Share Purchase Arecor Therapeutics Releases 2024 Annual Report and Announces AGM Arecor Therapeutics to Present Annual Results on Investor Platform PremiumCompany AnnouncementsArecor Partners to Innovate Peptide Therapy Formulation Arecor Therapeutics Reports 2024 Growth and Strategic Focus on Innovative Therapies Arecor Therapeutics Shifts Strategy, Ceases Tetris Pharma Operations